Under the guidance of Dr Matthew Blackledge, we are seeking to recruit a Postdoctoral Training Fellow to contribute to deliver treatment-integrated, multimodal agentic AI to drive a step-change in clinical radiotherapy by i) improving patient outcomes for cancers of unmet clinical need; and ii) increasing the efficiency of RT by enabling safe ultra-hypofractionated treatments. The successful candidate will play a key role in developing vision-language models (VLMs) to combine imaging data with human gestures (including eye gaze and voice-dictated prompts) for robust tumour delineation, and innovating Bayesian-enhanced AI to propagate uncertainties through the agentic workflow. The role will include attendance at relevant conferences and workshops, in addition to regular consultation with medical experts and publication of research in high-impact journals.
About you
The successful candidate must have:
1. A PhD in computational science, artificial intelligence
and/or image processing
2. Practical experience with Python programming.
3. Experience with medical datasets, including imaging,
clinical reports and/or radtiotherapy.
Candidates who are nearing completion of their PhD may apply, but confirmation on awarded PhD is required within 6 months of employment.
The ICR has a workforce agreement stating that Postdoctoral Training Fellows can only be employed for up to 7 years as PDTF at the ICR, providing total postdoctoral experience (including previous employment at this level elsewhere) does not exceed 7 years.
For general information on Postdocs at The ICR, more information can be found here.
Department/Directorate Information
Computational Imaging Group
The Blackledge Lab is based at the Institute of Cancer Research (ICR) in London, England. The lab was founded in 2019 with a focus on understanding the interface between medical imaging and computational science in oncology. In particular they aim to develop techniques that monitor imaging changes that inform on patient response and toxicity following radiotherapy. Our enthusiastic team of scientists are passionate to translate their research into clinically practical solutions in order to ensure that patients can benefit from emerging computational techniques. We actively engage with commercial partners to transfer our research into clinical tools.
The Division of Radiotherapy and Imaging
The Division of Radiotherapy and Imaging is investigating new imaging methods to diagnose cancer, and ways in which advances in technology and molecular biology can improve radiation treatment. It is also increasingly concerned with the use of imaging to evaluate the response to treatment in vivo, through techniques measuring aspects of tumour biology.
The ICR’s leading role in the development of intensity-modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT) has helped to change the way that radiotherapy is provided in the UK and
worldwide.
Researchers in the division are also interested in developing ways of increasing the effectiveness of radiotherapy by combining it with other treatments – including targeted drugs or viral therapies. A major research focus is the development of multimodality imaging for evaluating response to treatment in vivo. Novel imaging techniques can provide non-invasive assessments of various facets of tumour biology such as tumour angiogenesis, cell proliferation and hypoxia.
What we offer
4. A dynamic and supportive research environment
5. Access to state-of-the-art facilities and professional development opportunities
6. Collaboration with leading researchers in the field
7. Competitive salary and pension